AI Summary

A University of Barcelona study has identified the protein ENT1 as a new factor in the development of metabolic dysfunction‑associated steatotic liver disease (MASLD), the world’s most common chronic liver condition. ENT1 functions as a transporter that moves small molecules essential for liver cell function into cells. The researchers demonstrated ENT1’s role using both patient samples and animal models. These findings suggest that targeting ENT1 could be explored in future therapeutic approaches for MASLD.

AI summaries can be wrong sometimes—always verify important details using the source article.